Logo

Panagene Will Supply AdvanDx With PNA Probes for Its IVDs

Jun 12, 2007
NEW YORK (GenomeWeb News) — AdvanDx today said it will buy peptide nucleic acid probes from Panagene for use in its PNA FISH in vitro diagnostics.
 
AdvanDx’s molecular-based tests identify bacteria species associated with bloodstream infections from blood cultures. Panagene’s PNA probes target specific RNA in the bacteria, AdvanDx said.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.